Form 4: Merck & Co. Executive Sells Shares
Insider Transaction (Form 4)
David Michael Williams, EVP,Chief Info&Digital Officer of Merck & Co., Inc., sold 52,847 shares of common stock on August 5, 2026 for $128.77 per share.
Summary
- Option exercise/conversion: acquired 4,600 Common Stock at $77.62 ($357,052) on August 5, 2026; holds 36,316 after (Direct).
- Open-market sale: disposed of 4,600 Common Stock at $128.77 ($592,345) on August 5, 2026; holds 31,716 after (Direct).
- Option exercise/conversion: acquired 13,542 Common Stock at $75.36 ($1,020,525) on August 5, 2026; holds 45,258 after (Direct).
- Open-market sale: disposed of 13,542 Common Stock at $128.77 ($1,743,813) on August 5, 2026; holds 31,716 after (Direct).
- Option exercise/conversion: acquired 34,705 Common Stock at $73.73 ($2,558,800) on August 5, 2026; holds 66,421 after (Direct).
- Open-market sale: disposed of 34,705 Common Stock at $128.77 ($4,468,987) on August 5, 2026; holds 31,716 after (Direct).
- Option exercise/conversion: disposed of 4,600 Stock Option (Right to Buy) on August 5, 2026 (Direct).
- Option exercise/conversion: disposed of 13,542 Stock Option (Right to Buy) on August 5, 2026 (Direct).
- Option exercise/conversion: disposed of 34,705 Stock Option (Right to Buy) on August 5, 2026 (Direct).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $6,805,145 of stock on the open market.
Insider Transactions
David Michael Williams — Officer (EVP,Chief Info&Digital Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Option exercise/conversion | Common Stock | 4,600 | $78 | $357.1K | 36,316.037 |
| 2026-08-05 | Open-market sale | Common Stock | 4,600 | $129 | $592.3K | 31,716.037 |
| 2026-08-05 | Option exercise/conversion | Common Stock | 13,542 | $75 | $1.0M | 45,258.037 |
| 2026-08-05 | Open-market sale | Common Stock | 13,542 | $129 | $1.7M | 31,716.037 |
| 2026-08-05 | Option exercise/conversion | Common Stock | 34,705 | $74 | $2.6M | 66,421.037 |
| 2026-08-05 | Open-market sale | Common Stock | 34,705 | $129 | $4.5M | 31,716.037 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 4,600 | — | — | 0 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 13,542 | — | — | 0 |
| 2026-08-05 | Option exercise/conversion | Stock Option (Right to Buy) | 34,705 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Option exercise/conversion (4,600 shares) |
| 2026-08-05 | Open-market sale (4,600 shares) |
| 2026-08-05 | Option exercise/conversion (13,542 shares) |
| 2026-08-05 | Open-market sale (13,542 shares) |
| 2026-08-05 | Option exercise/conversion (34,705 shares) |
| 2026-08-05 | Open-market sale (34,705 shares) |
| 2026-08-05 | Option exercise/conversion (4,600 shares) |
| 2026-08-05 | Option exercise/conversion (13,542 shares) |
| 2026-08-05 | Option exercise/conversion (34,705 shares) |
Keywords
insider transaction, Form 4, MRK, Merck & Co., Inc., bearish, David Michael Williams
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.